ITGB4 and acute lymphoblastic leukemia: First, we treated four Ph‐positive ALL cell lines (KOPN30bi, KOPN55bi, KOPN66bi, and NALM27) with 0.5 μM of imatinib and evaluated their cell surface expression levels of CD49f, CD29, and CD104 by flow cytometry.